MedPath

Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing

Not Applicable
Recruiting
Conditions
Wound of Skin
Registration Number
NCT03346694
Lead Sponsor
Stanford University
Brief Summary

This study will evaluate two alternative dressings compared to a standard Island dressing presently in use at Stanford Hospital to determine reductions in surgical site infection (SSI) rates among cardiac surgery patients. Cardiovascular surgery patients who will have a sternotomy incision as a routine part of their surgery will be approached to voluntarily participate. Participants will be randomized to one of three dressing to determine which dressing has the lowest rate of sternal wound infection. The investigators will also assess the impact of alternative dressing use on hospital 30-day readmission rates related to SSI.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
660
Inclusion Criteria
  • Participants who will undergo cardiac surgery via a sternotomy incision.Inclusion criteria will be patients having surgical valve, CABGs, aortic dissection, myectomy and myotomy, Cox MAZE, Myocardial bridge Un-roofing
Exclusion Criteria
  • Patients undergoing heart transplants, Ventricular Assist Device (VAD), with postoperative courses complicated by tamponade, take-backs, and open chest incisions will also be excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Rates of surgical site infection pertaining to each dressing studied.From Post-Operative date 0 to 7th day or earlier which ever day comes first.

evaluate alternative dressings to determine reductions in surgical site infection (SSI) rates among cardiac surgery patients

Secondary Outcome Measures
NameTimeMethod
Impact of alternative dressings on rates of Sternal wound incision infection30 days after participant discharge.

Assess the impact of alternative dressing use on hospital 30-day readmission rates related to surgical site infection (SSI).

Trial Locations

Locations (1)

Stanford Healthcare

🇺🇸

Stanford, California, United States

Stanford Healthcare
🇺🇸Stanford, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.